# Endothelial Glycocalyx Degradation during Sepsis in Aging

> **NIH NIH R03** · UNIVERSITY OF COLORADO DENVER · 2022 · $155,500

## Abstract

Project Summary/Abstract
Sepsis, the body's injurious systemic response to infection, affects greater than 50 million patients world-wide
annually. Older people experience both an increased risk of sepsis onset as well as worse outcomes from
established sepsis. While many factors likely contribute to the disproportionate effect of sepsis on older
patients, recent studies have suggested important contributions of endothelial dysfunction to this disparity.
 The endothelial glycocalyx, a heparan sulfate (HS)-rich layer of glycosaminoglycans that lines the
vascular lumen, plays a central role in vascular homeostasis. Our laboratory has discovered that the
endothelial glycocalyx is degraded during sepsis, leading to local vascular dysfunction characteristic of septic
organ (e.g. lung and kidney) injury. Additionally, glycocalyx degradation releases biologically active HS
fragments into the circulation, impacting organ function systemically. We have previously found that sepsis-
released, circulating HS fragments selectively deposit within the hippocampus, the memory center of the brain.
These hippocampal-penetrating HS fragments inhibit brain-derived neurotrophic factor (BDNF), a growth factor
central to learning and memory, directly contributing to persistent cognitive dysfunction that affects the majority
of sepsis survivors.
 Preliminary studies to better understand septic endothelial glycocalyx degradation in aging
demonstrated that circulating levels of HS (a highly-sensitive measure of endothelial glycocalyx degradation)
are highest in older patients. Concordantly, HS elevations were more pronounced in aged (24 month-old)
compared to young (8 to 12 week-old) mice in a model of sepsis. The mechanisms responsible for this
increased severity of endothelial glycocalyx degradation in older patients is unknown. Additional preliminary
experiments suggest they these mechanisms be distinct from the known heparanase-dependence of
endothelial glycocalyx degradation in younger patients.
 This proposal will test the hypotheses that 1) the mechanism responsible for septic endothelial
glycocalyx degradation in older patients is distinct from that of younger patients (i.e. non-heparanase
dependent) and 2) endothelial glycocalyx degradation is responsible for worsened local organ injury during and
poor cognitive outcomes after sepsis in older mice. Critically, this work will allow Dr. Hippensteel to expand
upon his unique expertise studying the cognitive effects of critical illness, while serving as a launchpad for his
nascent career in the science of aging.

## Key facts

- **NIH application ID:** 10450710
- **Project number:** 5R03AG074056-02
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** Joseph Alan Hippensteel
- **Activity code:** R03 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $155,500
- **Award type:** 5
- **Project period:** 2021-07-15 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10450710

## Citation

> US National Institutes of Health, RePORTER application 10450710, Endothelial Glycocalyx Degradation during Sepsis in Aging (5R03AG074056-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10450710. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*